| Clinical data | |
|---|---|
| Other names | PiPT;N-Propyl-N-isopropyltryptamine |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H24N2 |
| Molar mass | 244.382 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Propylisopropyltryptamine (PiPT), also known asN-propyl-N-isopropyltryptamine, is apsychedelic drug of thetryptamine family. It reportedly produceshallucinogenic effects that resemble those of other related dialkyl tryptamine derivatives,[1] although PiPT is reportedly relatively weak and short-lasting. It has been sold as adesigner drug, first being identified in 2021 inBritish Columbia,Canada.[2]
According toAlexander Shulgin in his 1997 bookTiHKAL (Tryptamines I Have Known and Loved), PiPT had not yet been evaluated.[3]
PiPT is short forN-propyl-N-isopropyltryptamine. PiPT is a tryptamine, which all belong to a larger family of compounds known asindolethylamines
Analogues of PiPT includemethylisopropyltryptamine (MiPT),ethylisopropyltryptamine (EiPT),diisopropyltryptamine (DiPT), anddipropyltryptamine (DPT), among others.[3]
PiPT is unscheduled and uncontrolled in the United States.[citation needed]